Axel Becker

USPTO Granted Patents = 10 (Patent Applications = 4)

CIPO Patents = 7 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 10)

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 15(Granted Patents)

Location History:

Troisdorf, DE (2006)
Darmstadt, DE (2013 - 2016)
Seeheim-Jugenheim, DE (2019 - 2021)

Company Filing History:

Reifenhäuser Gmbh & Co. Maschinenfabrik

patents

Years Active: 2006-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12344604 - Imidazolonylquinoline compounds and therapeutic uses thereof (2025-07-01),

2. 10981864 - Crystalline modifications of N-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine hydrochloride and N-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine salts (2021-04-20),

3. 10689363 - Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone (2020-06-23),

4. 10464923 - Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone (2019-11-05),

5. 9308205 - Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyrdazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof (2016-04-12),

6. 9289427 - Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-hydrochloride salt and processes of manufacturing thereof (2016-03-22),

7. 9260393 - Solid state forms of N-((S)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide (2016-02-16),

8. 8710058 - Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof (2014-04-29),

9. 8586599 - Polymorphic forms of 6-(1-methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2H-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof (2013-11-19),

10. 7004738 - Apparatus for producing melt-blown webs (2006-02-28),

Title: Axel Becker: Innovator in Pharmaceutical Chemistry

Introduction

Axel Becker, an accomplished inventor based in Darmstadt, Germany, has made significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio of 8 patents, he has focused on developing innovative compounds that hold promise in the medical field.

Latest Patents

Among his latest patents are noteworthy inventions such as crystalline modifications of N-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine hydrochloride and N-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine salts. This invention pertains to novel crystalline forms of these compounds, alongside the processes of manufacturing and pharmaceutical formulations. Another significant patent involves the crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone, which are recognized for their utility as BTK inhibitors.

Career Highlights

Axel Becker is currently associated with Merck Patent GmbH, where he continues to advance his research and innovation efforts. His work has garnered recognition within the pharmaceutical community, evidencing the importance of his contributions to drug development and therapeutic methods.

Collaborations

Throughout his career, Becker has collaborated with notable colleagues such as Christoph Saal and Clemens Kuehn. These collaborations have facilitated advancements in their mutual areas of research, allowing for the sharing of insights and expertise that enhance their collective contributions to the field.

Conclusion

Axel Becker stands out as an influential inventor in the realm of pharmaceutical innovations. His extensive patent portfolio reflects his dedication to advancing medical science through innovative approaches to drug formulation and therapeutic design. As he continues his work at Merck Patent GmbH, the impact of his inventions will likely resonate within the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.